glp-1 receptor pathway GLP-1R Signaling and Functional Molecules in Incretin Therapy Perspectives in GLP-1 Research: New

Gelling, R

Indeed, adverse GI effects such as nausea may be more frequently experienced by women as demonstrated by a study on cotadutide (dual agonist of the GLP-1 and glucagon receptors), which attributed this effect to slower drug absorption rates in women (79)

The ongoing CONFIDENCE trial (NCT05254002) is an international randomised controlled double-blind trial that will directly assess the effects of finerenone plus empagliflozin on albuminuria and characterise the efficacy and safety of this drug combination in the setting of type 2 diabetes

Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al

Consult with a Professional Before starting GLP-1 therapy, its essential to consult a qualified healthcare provider